North America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis

The North America Cardiopulmonary Oxygenator Market was valued at US$ 261.35 million in 2022 and is expected to reach US$ 334.51 million by 2028. It is estimated to register a CAGR of 4.2% from 2022 to 2028.

Increasing Surgical Procedures with Surging in Aging Population is Fueling North America Cardiopulmonary Oxygenator Market

Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.

According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.

North America Cardiopulmonary Oxygenator Market Overview

The cardiopulmonary oxygenators market in North America is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the rising prevalence of cardiovascular and respiratory disorders in the region. This has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. For instance, as per American Lung Association, ~12.5 million people are diagnosed with COPD, chronic bronchitis, and emphysema in the US in 2020. Moreover, rising prevalence and incidences of such disorders have increased the number of surgical procedures among large patient population which has fueled the growth of cardiopulmonary oxygenator market. For instance, as per study published by lifespan health system, ~500,00 open heart surgeries are performed in the US every year. Additionally, increase in prevalence of respiratory failure and infectious diseases are further expected to create demand for cardiopulmonary oxygenator.

Furthermore, rising prevalence of cardiovascular disorders are the leading cause of death on the global level and oxygenator can be of great assistance in lifesaving in emergency cases. As per world health organization, ~17.9 million lives are lost due to CVDs annually. Moreover, favorable reimbursement policies are also expected to create ample opportunities for the growth of cardiopulmonary oxygenator. Therefore, rising prevalence and incidence of cardiopulmonary disorders are expected to drive the growth of cardiopulmonary oxygenator market during the forecast period.

North America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiopulmonary Oxygenator Market Segmentation

The North America Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.